CIVQX Fees and Costs — Clifford Capital International Value Fund, Super Inst'l

Data updated: 2024-12-13

The net expense ratio is 0.97% (26.69% before fee waivers). There are no sales loads or redemption fees. In fiscal 2024 the fund paid $1K in broker commissions, 0.0294% of average net assets, and portfolio turnover was 11%.

CIVQX Fees and Expenses

Annual operating expenses and sales charges of CIVQX. Prospectus, as of January 31, 2024.

Annual operating expenses
Management fee0.85%
12b-1 fee—
Other expenses—
Gross expense ratio26.69%
Fee waiver−25.72%
Net expense ratio0.97%
Sales charges
Max front load—
Max deferred load—
Redemption fee0.00%
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

CIVQX Costs Over Time

On $10,000 invested in CIVQX, assuming 5% a year before costs, total costs come to $625 over 5 years, cutting the return by 1.05% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.97%)$102$318$551
Trading costs (broker commissions)$3$10$17
Lost growth on money paid in costs$0$16$57
Total costs$105$344$625
Value after costs$10,395$11,233$12,138
Impact on return, per year1.05%1.05%1.05%

CIVQX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.

  • Explicit cost rate (commissions ÷ average net assets): 0.0294%
  • Total broker commissions: $1K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 11%
  • Securities lending: none during the year

CIVQX Agency Brokers

Commissions paid.

BrokerAmountShare
Loop Capital Markets LLC$1K94.14%
Pennhaven Brokerage Partners, LLC$835.86%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.